Human Molecular Genetics Advance Access originally published online on May 22, 2006
Human Molecular Genetics 2006 15(13):2087-2097; doi:10.1093/hmg/ddl132
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
1 Department of Neuroscience and 2 Department of Neurology, Box 673, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA and 3 Department of Molecular Genetics and Microbiology and the Genetics Institute, University of Florida, College of Medicine, Gainesville, FL 32610, USA
* To whom correspondence should be addressed. Tel: +1 5852752542; fax: +1 5852731255; Email: charles_thornton{at}urmc.rochester.edu
Received April 11, 2006; Accepted May 14, 2006
In myotonic dystrophy (DM), expression of RNA containing expanded CUG or CCUG repeats leads to misregulated alternative splicing of pre-mRNA. The repeat-bearing transcripts accumulate in nuclear foci, together with proteins in the muscleblind family, MBNL1 and MBNL2. In transgenic mice that express expanded CUG repeats, we show that the splicing defect selectively targets a group of exons that share a common temporal pattern of developmental regulation. These exons undergo a synchronized splicing switch between post-natal day 2 and 20 in wild-type mice. During this post-natal interval, MBNL1 protein translocates from a predominantly cytoplasmic to nuclear distribution. In the absence of MBNL1, these physiological splicing transitions do not occur. The splicing defect induced by expanded CUG repeats in mature muscle fibers is closely reproduced by deficiency of MBNL1 but not by deficiency of MBNL2. A parallel situation exists in human DM type 1 and type 2. MBNL1 is depleted from the muscle nucleoplasm because of sequestration in nuclear foci, and the associated splicing defects are remarkably similar to those observed in MBNL1 knockout mice. These results indicate that MBNL1 participates in the post-natal remodeling of skeletal muscle by controlling a key set of developmentally regulated splicing switches. Sequestration of MBNL1, and failure to maintain these splicing transitions, has a pivotal role in the pathogenesis of muscle disease in DM.
Present address: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. B. Warf, M. Nakamori, C. M. Matthys, C. A. Thornton, and J. A. Berglund From the Cover: Pentamidine reverses the splicing defects associated with myotonic dystrophy PNAS, November 3, 2009; 106(44): 18551 - 18556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kino, C. Washizu, Y. Oma, H. Onishi, Y. Nezu, N. Sasagawa, N. Nukina, and S. Ishiura MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1 Nucleic Acids Res., October 1, 2009; 37(19): 6477 - 6490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, A. M. Wang, D. M. Robins, and A. P. Lieberman Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice Dis. Model. Mech., September 1, 2009; 2(9-10): 500 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. M. Mulders, W. J. A. A. van den Broek, T. M. Wheeler, H. J. E. Croes, P. van Kuik-Romeijn, S. J. de Kimpe, D. Furling, G. J. Platenburg, G. Gourdon, C. A. Thornton, et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy PNAS, August 18, 2009; 106(33): 13915 - 13920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Salisbury, B. Schoser, C. Schneider-Gold, G.-L. Wang, C. Huichalaf, B. Jin, M. Sirito, P. Sarkar, R. Krahe, N. A. Timchenko, et al. Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients Am. J. Pathol., August 1, 2009; 175(2): 748 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wheeler, K. Sobczak, J. D. Lueck, R. J. Osborne, X. Lin, R. T. Dirksen, and C. A. Thornton Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA Science, July 17, 2009; 325(5938): 336 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Cudia, P Bernasconi, R Chiodelli, F Mangiola, F Bellocci, A D. Russo, C Angelini, V Romeo, P Melacini, L Politano, et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 790 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Osborne, X. Lin, S. Welle, K. Sobczak, J. R. O'Rourke, M. S. Swanson, and C. A. Thornton Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy Hum. Mol. Genet., April 15, 2009; 18(8): 1471 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Holt, V. Jacquemin, M. Fardaei, C. A. Sewry, G. S. Butler-Browne, D. Furling, J. D. Brook, and G. E. Morris Muscleblind-Like Proteins: Similarities and Differences in Normal and Myotonic Dystrophy Muscle Am. J. Pathol., January 1, 2009; 174(1): 216 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kalsotra, X. Xiao, A. J. Ward, J. C. Castle, J. M. Johnson, C. B. Burge, and T. A. Cooper A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart PNAS, December 23, 2008; 105(51): 20333 - 20338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Botta, F Rinaldi, C Catalli, L Vergani, E Bonifazi, V Romeo, E Loro, A Viola, C Angelini, and G Novelli The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients J. Med. Genet., October 1, 2008; 45(10): 639 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Osborne and C. A. Thornton Cell-free cloning of highly expanded CTG repeats by amplification of dimerized expanded repeats Nucleic Acids Res., March 27, 2008; 36(4): e24 - e24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakamori, T. Kimura, T. Kubota, T. Matsumura, H. Sumi, H. Fujimura, M. P. Takahashi, and S. Sakoda Aberrantly spliced {alpha}-dystrobrevin alters {alpha}-syntrophin binding in myotonic dystrophy type 1 Neurology, February 26, 2008; 70(9): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Orengo, P. Chambon, D. Metzger, D. R. Mosier, G. J. Snipes, and T. A. Cooper Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy PNAS, February 19, 2008; 105(7): 2646 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ciafaloni, E. Mignot, V. Sansone, J. E. Hilbert, L. Lin, X. Lin, L. C. Liu, W. R. Pigeon, M. L. Perlis, and C. A. Thornton The hypocretin neurotransmission system in myotonic dystrophy type 1 Neurology, January 15, 2008; 70(3): 226 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Hino, S. Kondo, H. Sekiya, A. Saito, S. Kanemoto, T. Murakami, K. Chihara, Y. Aoki, M. Nakamori, M. P. Takahashi, et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1 Hum. Mol. Genet., December 1, 2007; 16(23): 2834 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Warf and J. A. Berglund MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T RNA, December 1, 2007; 13(12): 2238 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Smith, M. Byron, C. Johnson, Y. Xing, and J. B. Lawrence Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains J. Cell Biol., September 7, 2007; 178(6): 951 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yuan, S. A. Compton, K. Sobczak, M. G. Stenberg, C. A. Thornton, J. D. Griffith, and M. S. Swanson Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs Nucleic Acids Res., August 15, 2007; (2007) gkm601v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Moroy and F. Heyd The impact of alternative splicing in vivo: Mouse models show the way RNA, August 1, 2007; 13(8): 1155 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lueck, C. Lungu, A. Mankodi, R. J. Osborne, S. L. Welle, R. T. Dirksen, and C. A. Thornton Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1 Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1291 - C1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Cooper Regulation of chloride ion conductance during skeletal muscle development and in disease. Focus on "Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1" Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1245 - C1247. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Cooper A Reversal of Misfortune for Myotonic Dystrophy? N. Engl. J. Med., October 26, 2006; 355(17): 1825 - 1827. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Osborne and C. A. Thornton RNA-dominant diseases Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Kanadia, J. Shin, Y. Yuan, S. G. Beattie, T. M. Wheeler, C. A. Thornton, and M. S. Swanson Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy PNAS, August 1, 2006; 103(31): 11748 - 11753. [Abstract] [Full Text] [PDF]
|
|